Vocabria (Cabotegravir)

Buy Vocabria at huge discount - European product

Marketing Authorisation Holder ViiV Healthcare BV Van Asch van Wijckstraat 55H, 3811 LP Amersfoort Netherlands Manufacturer Glaxo Wellcome, S.A. Avda. Extremadura, 3 Aranda De Duero Burgos 09400 Spain

Information about Vocabria (Cabotegravir)

Vocabria is a medication that contains cabotegravir, an antiretroviral drug used to treat HIV (human immunodeficiency virus) infection. It belongs to a class of drugs known as integrase strand transfer inhibitors (INSTIs). Cabotegravir works by inhibiting the HIV integrase enzyme, which is necessary for the virus to replicate and integrate its genetic material into the host's DNA. By blocking this process, Vocabria helps reduce the viral load in the body, preventing the progression of HIV to AIDS and improving overall immune function.

Product Highlights

• Vocabria is primarily indicated for the treatment of HIV-1 infection in adults and pediatric patients. It is used in combination with other HIV medications as part of a complete treatment regimen.
• In some cases, cabotegravir is used as a long-acting injectable option for HIV maintenance therapy, offering an alternative to daily oral medications.

Key Ingredient

• Cabotegravir

Key Benefits

• Cabotegravir works by reducing HIV viral load, helping to control the infection and prevent the development of AIDS when used consistently with other antiretroviral medications.
• For patients who prefer not to take daily oral HIV medications, Vocabria offers a long-acting injectable formulation. This reduces the need for daily dosing and can improve adherence to treatment.
• When used as prescribed, Vocabria generally has a manageable side effect profile, with fewer drug interactions compared to some other HIV medications.
• By effectively controlling the virus, Vocabria allows patients to lead healthier lives with a reduced risk of HIV-related complications.
• Cabotegravir is often used in combination with other HIV drugs, maximizing treatment effectiveness and reducing the chance of drug resistance.

Direction of Use

• When used as part of an oral regimen, the typical dosage is 30 mg once daily. It's important to take Vocabria exactly as prescribed, without missing doses, to maintain viral suppression.
• Cabotegravir is also available as an injectable formulation, typically administered once a month or every two months, depending on the specific treatment plan.
• For both the oral and injectable forms, consistency is crucial to maintaining effective viral suppression. It’s important not to miss doses and to follow up with your healthcare provider regularly for assessments.

Safety Concerns

• Some individuals may experience liver enzyme elevations or liver dysfunction. Liver function should be monitored regularly throughout the course of treatment. 
• If Vocabria is not taken as prescribed or if doses are missed, there is a risk of the virus developing resistance to the drug. Adhering to the prescribed regimen is essential for effective treatment. 
• Common side effects of cabotegravir may include fatigue, headache, nausea, diarrhea, and injection site reactions (for the injectable form). Rarely, more severe side effects, like allergic reactions or significant liver problems, may occur.
• While cabotegravir is not known to cause harm to an unborn baby, its safety during pregnancy is not fully established. Pregnant women should consult their healthcare provider. Cabotegravir may also pass into breast milk, so breastfeeding while using this medication is generally not recommended unless advised by a doctor.
• In patients who start HIV treatment, there is a risk of IRIS, where the immune system begins to respond to long-hidden infections. Monitoring for symptoms of IRIS is necessary, particularly when starting treatment for advanced HIV.

Avoid Vocabria (Cabotegravir) If

• Do not use Vocabria if you have a known hypersensitivity or allergy to cabotegravir or any of its components.
• Avoid using Vocabria in patients with severe hepatic impairment (liver disease), as the medication may exacerbate liver problems.
• Vocabria should only be used during pregnancy if clearly needed and prescribed by a healthcare provider. Adequate pregnancy counseling should be done.
• Avoid breastfeeding while taking Vocabria, as the drug can pass into breast milk and affect a nursing infant.
• If you have acute or active hepatitis, you should not use Vocabria without careful medical supervision, as it can affect liver function.